glp-1-directed nmda receptor antagonism for obesity treatment Treating using glucagon-like peptide-1-directed N-methyl-D-aspartate inhibition Nature：重大进展！利用减肥激素GLP-1递送阻断NMDA受体的小分子到大脑中，可显著达到减肥效果- 生物研究专区- 生物谷

glp-1-directed nmda receptor antagonism for obesity treatment

glp-1-directed nmda receptor antagonism for obesity treatment Treating using glucagon-like peptide-1-directed N-methyl-D-aspartate inhibition Nature：重大进展！利用减肥激素GLP-1递送阻断NMDA受体的小分子到大脑中，可显著达到减肥效果- 生物研究专区- 生物谷

Name: glp-1-directed nmda receptor antagonism for obesity treatment Treating using glucagon-like peptide-1-directed N-methyl-D-aspartate inhibition Nature：重大进展！利用减肥激素GLP-1递送阻断NMDA受体的小分子到大脑中，可显著达到减肥效果- 生物研究专区- 生物谷
Brand: themeproject.nl
SKU: 1580304347
Price: 26.34 USD
Availability: InStock
Rating: 4.5364 (29 reviews)

SKU: 1580304347

4.5

USD26.34 USD68.34

Pay in 4 interest-free payments of $6.58 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Description

Lukes Medical Center- Houston and the Thomas Street HIV-Health Center

Production of [14C] (lactate +pyruvate) and carbon dioxide by 1 mL erythrocytes incubated for 1 hour with 10 mmol /L [14C]glucose at 10 Ci /mmol

Ozempic is a once-weekly injectable with the active ingredient semaglutide

Optimization of antioxidant activity properties of a thermosonicated beetroot ( Beta vulgaris L.) juice and further in vitro bioaccessibility comparison with thermal treatments